Article Text

Reminder of important clinical lesson
Hydroxychloroquine: a diabetic drug in disguise?
  1. Lydia Kang1,
  2. Ted R Mikuls2,
  3. James R O’Dell2
  1. 1
    University of Nebraska Medical Center, General Internal Medicine, MSB 5544, 983331, Omaha, Nebraska, 68198-3331, USA
  2. 2
    University of Nebraska Medical Center, Rheumatology, 983025 Nebraska Medical Center, Omaha, Nebraska, 68198-3025, USA
  1. lkang{at}unmc.edu

Summary

Hydroxychloroquine (HCQ) is an antimalarial agent that is commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present report documents a case of hypoglycaemia due to HCQ in a patient with SLE and diabetes mellitus type 2, in which the HCQ completely replaced the need for daily subcutaneous insulin.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.